---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-035286"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2025-09-18T23:59:59+00:00"
generated_at: "2026-05-17T06:14:01.006355+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics closes $10M public offering of 5M shares and warrants

## Summary
- Gross proceeds of $10M from sale of 5M shares and Series E/F warrants to purchase up to 10M shares.
- Net proceeds approximately $9.0M after placement agent fees and offering expenses.
- Warrants exercisable at $2.00 per share; Series E expire in 5 years, Series F in 18 months.
- Proceeds to be used for working capital and general corporate purposes.
- Offering closed on September 17, 2025; H.C. Wainwright acted as exclusive placement agent.

## SEC filing metadata
- accession: 0001140361-25-035286
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2025-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036125035286/0001140361-25-035286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036125035286/ny20052513x7_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-035286
- JSON: https://secwatch.observer/filing/0001140361-25-035286.json
- Plain text: https://secwatch.observer/filing/0001140361-25-035286.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.